CLB - NYSE

Core Laboratories N.V.

CLB·NYSE

$13.69

+0.66%

EnergyOil & Gas Equipment & Services

Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$631.06M

EPS0.6800

P/E Ratio20.13

Earnings Date07/29/2026

596.95M

Assets

3Y+3.0%

5Y+5.0%

10Y+4.0%

317.19M

Total Liabilities

-5%

3Y-19.0%

5Y-36.0%

10Y-24.0%

279.76M

Total Equity

3Y+48.0%

5Y+270.0%

10Y+76.0%

Core Laboratories N.V. Funding & Solvency Profile

CLB · NYSE

Current Assets

Cash & Cash Equivalents22.85M

Net Receivables113.53M

Inventory54.50M

Other Current Assets31.50M

Total Current Assets222 M

Non-Current Assets

Property, Plant & Equipment153.79M

Goodwill & Intangible Assets220.79M

Long-Term Investments0.00

Other Non-Current Assets0.00

Total Non-Current Assets154 M

Total Assets

596.95M

Financial Health Analysis

Current Ratio

2.07x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

1.13x

Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.

Working Capital

115 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

37% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Core Laboratories N.V. Balance Sheet

CLB • NYSE

Core Laboratories N.V. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	22.8M	19.2M	15.1M	15.4M	17.7M	13.8M	11.1M	13.1M	14.4M	14.8M	22.5M	23.4M	25.1M	19.2M	29.3M	133.9M	181M	36.1M	25.6M	54.2M
Cash & Short-Term Investments	22.8M	19.2M	15.1M	15.4M	17.7M	13.8M	11.1M	13.1M	14.4M	14.8M	22.5M	23.4M	25.1M	19.2M	29.3M	133.9M	181M	36.1M	25.6M	54.2M
Net Receivables	113.5M	127.4M	123.1M	115.1M	106.7M	83.2M	138.1M	129.2M	133.1M	114.3M	145.7M	197.2M	201.3M	202.7M	178M	154.7M	133.8M	144.3M	108.3M	112.1M
Accounts Receivables	113.5M	111.8M	109.4M	106.9M	96.8M	83.2M	131.6M	129.2M	133.1M	114.3M	145.7M	197.2M	201.3M	184.8M	170.8M	154.7M	133.8M	144.3M	108.3M	112.1M
Other Receivables	0.0	15.6M	13.7M	8.2M	9.9M	0.0	6.5M	0.0	0.0	0.0	0.0	0.0	0.0	17.9M	0.0	0.0	0.0	0.0	0.0	0.0
Inventory	54.5M	59.4M	71.7M	60.4M	45.4M	38.2M	50.2M	45.7M	33.3M	33.7M	40.9M	43.4M	46.8M	49.3M	53.2M	34M	32.2M	34.8M	29.4M	30.2M
Prepaids	0.0	10.2M	8.2M	15.7M	14.1M	14.8M	16M	15.4M	12.6M	10.7M	12.1M	14.2M	13.1M	15M	14M	26.7M	43.6M	20.4M	28.5M	29.1M
Other Current Assets	31.5M	10.5M	5.1M	5.1M	5.1M	15.9M	5.9M	27.7M	14M	12.9M	17.4M	23.7M	17.5M	10.7M	12M	0.0	0.0	0.0	28.9M	0.0
Total Current Assets	222.4M	226.6M	223.1M	211.7M	189.1M	165.8M	221.2M	231M	207.4M	186.5M	238.5M	301.8M	303.9M	296.9M	280.8M	349.3M	390.5M	242M	220.7M	225.6M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	153.8M	153.6M	153.5M	157.4M	172.3M	181.7M	199.2M	122.9M	123.1M	129.9M	143.2M	149M	138.8M	125.4M	115.3M	104.2M	98.8M	103.5M	93M	87.7M
Goodwill	0.0	99.4M	99.4M	99.4M	99.4M	99.4M	213.4M	219.4M	179M	179M	178.2M	164.5M	163.3M	163.3M	162.8M	154.2M	148.6M	148.6M	138.8M	132.6M
Intangible Assets	220.8M	6.4M	6.9M	7.5M	8.1M	8.6M	17.5M	13.1M	9.4M	9.9M	10M	10.6M	10.9M	8.7M	8.2M	8.7M	6.5M	7M	7M	6.6M
Goodwill & Intangible Assets	220.8M	105.8M	106.4M	106.9M	107.6M	108M	230.9M	294.9M	254.3M	256.7M	243.5M	224.8M	218.3M	214.2M	171M	162.9M	155.1M	155.6M	145.8M	139.2M
Long-Term Investments	0.0	5.1M	4.8M	4.5M	4.2M	4.1M	4M	3.8M	3.6M	3.2M	2.7M	2.3M	1.9M	1.9M	0.0	0.0	-14.4M	0.0	0.0	0.0
Tax Assets	0.0	69.6M	0.0	68.6M	70.5M	72.8M	67.3M	11.3M	10.7M	20.6M	11.7M	3.9M	4.5M	13.2M	13.7M	0.0	14.4M	27.4M	26M	33M
Other Non-Current Assets	0.0	29.7M	98.6M	29.3M	37.3M	36.2M	52.1M	-15M	-14.3M	-23.8M	-14.4M	-6.2M	-6.4M	-15.1M	24.4M	19.6M	13.7M	9.1M	19.2M	15.7M
Total Non-Current Assets	374.6M	363.8M	363.3M	366.7M	391.8M	402.7M	553.4M	417.9M	377.4M	386.6M	386.7M	373.8M	357.1M	339.6M	324.3M	286.7M	267.6M	295.6M	284.1M	275.7M
Total Assets	597M	590.4M	586.4M	578.4M	580.9M	568.6M	774.7M	648.8M	584.8M	573.1M	625.3M	675.7M	661M	636.5M	605.1M	636M	658.2M	537.7M	504.8M	501.2M
LIABILITIES
CURRENT LIABILITIES
Total Payables	37.3M	46.5M	40.8M	48.9M	36.2M	31.4M	41.9M	44.1M	41.7M	49.4M	35.2M	55.4M	50.8M	76.5M	58.4M	73.5M	48.4M	49.5M	39.9M	37.5M
Accounts Payable	37.3M	34.5M	33.5M	45.8M	29.7M	23M	35.6M	41.2M	41.7M	33.7M	33.5M	47.1M	50.8M	55.2M	57.6M	44.7M	33M	41.6M	39.9M	37.5M
Other Payables	0.0	12M	7.3M	3M	6.5M	8.3M	6.3M	2.9M	0.0	15.7M	1.7M	8.3M	0.0	21.3M	793K	28.8M	15.4M	7.9M	0.0	0.0
Accrued Expenses	0.0	22.9M	18.8M	23.4M	20.8M	26.5M	26.7M	22.5M	28.9M	19.4M	36.5M	34.6M	39M	34.9M	34M	38.1M	24.4M	28.6M	37.2M	33.1M
Short Term Debt	0.0	0.0	0.0	0.0	0.0	0.0	11.8M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3M	0.0	0.0	0.0	3M	2.8M
Capital Lease Obligations (Current)	11.5M	10.7M	10.2M	11.7M	12.3M	11.4M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Payables	0.0	12M	7.3M	7.9M	12.4M	14.9M	6.3M	10.4M	8.1M	21.5M	11.2M	19.5M	21.4M	21.3M	9.4M	28.8M	23.6M	7.9M	0.0	8.7M
Deferred Revenue	0.0	9.3M	4.8M	5.9M	7.8M	5.5M	13.4M	17.3M	17.1M	15.7M	14.1M	11M	10.9M	13.9M	19.2M	20.2M	16.5M	0.0	9.1M	6.9M
Other Current Liabilities	58.4M	8.2M	13.6M	13.2M	13.6M	15M	17.7M	18.6M	30M	19.5M	35M	30.8M	35.1M	15.2M	23.5M	167.7M	33.6M	17.5M	8.8M	8.7M
Total Current Liabilities	107.2M	97.6M	88.1M	103.1M	90.8M	89.8M	111.6M	102.5M	105M	104M	120.8M	131.9M	135.8M	140.5M	137.5M	279.4M	106.4M	95.7M	98M	88.9M
NON-CURRENT LIABILITIES
Long Term Debt	152.6M	126.1M	163.1M	172.4M	188.6M	259.4M	305.3M	289.8M	227M	216.5M	431M	353.7M	267M	234M	223.1M	8.9M	209.1M	238.7M	300M	300M
Deferred Revenue (Non-Current)	0.0	0.0	30.5M	31.8M	39.1M	39.1M	50.5M	1.4M	-5.3M	-6.3M	-4.9M	-7.2M	-8.9M	-6.8M	24.1M	21.2M	16.9M	8.1M	0.0	0.0
Deferred Tax Liabilities (Non-Current)	0.0	13.8M	12.7M	22.9M	24.3M	20.6M	27.3M	7.6M	5.3M	6.3M	4.9M	7.2M	8.9M	6.8M	5.5M	2.2M	7.7M	4.7M	0.0	0.0
Other Non-Current Liabilities	15.1M	51.8M	20M	20.9M	27.7M	28M	33.2M	37.2M	46M	91M	92.3M	88.9M	80M	67.3M	33.3M	32M	36.3M	30.2M	43.1M	39M
Total Non-Current Liabilities	210M	235.1M	268.5M	286.3M	329.1M	403.3M	480.9M	385.4M	331.1M	313.7M	528.2M	449.8M	355.8M	308.1M	286M	64.3M	270M	281.7M	343.1M	339M
Capital Lease Obligations	53.8M	54M	52.3M	50M	61.6M	67.5M	64.7M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	317.2M	332.7M	356.6M	389.4M	419.9M	493M	592.5M	487.9M	436.1M	417.8M	649M	581.7M	491.6M	448.6M	423.5M	343.7M	376.4M	377.3M	441.2M	427.9M
SHAREHOLDERS' EQUITY
Treasury Stock	0.0	-2.5M	-1.4M	-1.4M	-4.1M	-14.1M	-29.4M	-52.5M	-76.3M	-80.8M	-238.9M	-317.6M	-245.2M	-171.8M	-107.4M	-242.7M	-246.7M	-245.7M	-1.9M	-174.8M
Preferred Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1M	3.9M	3.9M	5.4M	6.4M	6.1M	5.7M	0.0	0.0	0.0	0.0	0.0	0.0
Common Stock	279.8M	470K	469K	1.2M	1.2M	1.1M	1.1M	1.1M	1.1M	1.1M	1.1M	1.2M	1.2M	1.2M	1.4M	1.4M	1.4M	1.4M	1.3M	1.5M
Additional Paid-In Capital	0.0	109.5M	110M	102.3M	101.1M	41.2M	51.9M	57.4M	54.5M	52.9M	0.0	0.0	0.0	0.0	2M	0.0	61.7M	53M	0.0	23.2M
Retained Earnings	0.0	150.3M	120.8M	85.9M	68.3M	50.5M	160.5M	156.1M	173.9M	188M	219.2M	415.9M	415.9M	361.3M	283.7M	537M	469.5M	406.2M	62.5M	224.1M
Accumulated Other Comprehensive Income/Loss	0.0	-5.8M	-5M	-3.8M	-10.1M	-7.2M	-6.3M	-5.5M	-8.4M	-9.8M	-10.5M	-11.9M	-8.6M	-8.4M	-1.7M	-6.2M	0.0	-4.9M	226K	-2.1M
Total Stockholders' Equity	279.8M	252M	224.8M	184.3M	156.4M	71.5M	177.9M	160.9M	148.7M	155.3M	-23.7M	94M	169.4M	187.9M	177.9M	289.5M	279.4M	158.2M	62.1M	71.8M
Total Equity	279.8M	257.7M	229.8M	189M	161M	75.6M	182.1M	165M	152.6M	159.2M	-18.3M	100.4M	175.5M	193.6M	181.7M	292.3M	281.8M	160.3M	63.6M	73.3M
Minority Interest	0.0	5.7M	5M	4.7M	4.6M	4.1M	4.3M	4.1M	3.9M	3.9M	5.4M	6.4M	6.1M	5.7M	3.8M	2.8M	2.4M	2.2M	1.5M	1.4M
SUMMARY
Total Liabilities & Equity	597M	590.4M	586.4M	578.4M	580.9M	568.6M	774.7M	648.8M	584.8M	573.1M	625.3M	675.7M	661M	636.5M	605.1M	636M	658.2M	537.7M	504.8M	501.2M
Total Investments	0.0	5.1M	4.8M	4.5M	4.2M	4.1M	4M	3.8M	3.6M	3.2M	2.7M	2.3M	1.9M	1.9M	0.0	0.0	-14.4M	0.0	0.0	0.0
Total Debt	206.3M	180.1M	215.4M	222.4M	250.3M	327M	381.8M	289.8M	227M	216.5M	431M	356M	267M	234.1M	225.4M	156.4M	209.1M	238.7M	303M	302.8M
Net Debt	183.5M	161M	200.3M	207M	232.6M	313.2M	370.7M	276.7M	212.6M	201.7M	408.5M	332.7M	241.9M	214.8M	196.1M	22.5M	28.1M	202.5M	277.4M	248.5M
Shares Outstanding	46,096,682	46,096,682	46,096,682	46,096,682	46,096,682	46,096,682	46,096,682	46,096,682	46,096,682	46,096,682	46,096,682	46,096,682	46,096,682	46,096,682	46,096,682	46,096,682	46,096,682	46,096,682	46,096,682	46,096,682

SEC Filings

CLB - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
DEF 14A DEF 14A N/A	April 28, 2023	April 28, 2023		View Filing
10-Q 10-Q 2023 Q1 Q1	April 27, 2023	March 31, 2023	2023	View Filing
8-K 8-K 2023 N/A	April 26, 2023	April 26, 2023	2023	View Filing
8-K 8-K 2023 N/A	April 04, 2023	April 03, 2023	2023	View Filing
10-K 10-K 2022 FY FY	February 10, 2023	December 31, 2022	2022	View Filing
8-K 8-K 2023 N/A	February 03, 2023	February 02, 2023	2023	View Filing
8-K 8-K 2023 N/A	February 01, 2023	February 01, 2023	2023	View Filing
8-K 8-K 2023 N/A	January 17, 2023	January 17, 2023	2023	View Filing
8-K 8-K 2022 N/A	November 04, 2022	November 04, 2022	2022	View Filing
10-Q 10-Q 2022 Q3 Q3	October 28, 2022	September 30, 2022	2022	View Filing

Showing 1 to 10 of 372 filings

Related Guides

Blog Categories

Continue your CLB research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.